# Clinical Evaluation Report (CER) Template

**Regulatory Reference**: MEDDEV 2.7.1 rev 4
**Template Version**: 1.0.0
**Last Updated**: 2025-02-09
**Valid For**: EU MDR Clinical Evaluation Requirements

---

## Document Information

| Field | Value |
|-------|-------|
| **Device Name** | [Enter device name] |
| **Manufacturer** | [Enter manufacturer name] |
| **CER Version** | [Enter version number] |
| **Date of Issue** | [Enter date] |
| **Evaluation Period** | [Start date] to [End date] |
| **CER Responsible Person** | [Enter name and qualifications] |

---

## Revision History

| Version | Date | Changes | Author |
|---------|------|---------|--------|
| 1.0 | [Date] | Initial release | [Name] |

---

## Table of Contents

1. [Executive Summary](#1-executive-summary)
2. [Scope and Purpose](#2-scope-and-purpose)
3. [Device Description](#3-device-description)
4. [Intended Purpose and Indications for Use](#4-intended-purpose-and-indications-for-use)
5. [Clinical Evaluation Methodology](#5-clinical-evaluation-methodology)
6. [Literature Search Strategy](#6-literature-search-strategy)
7. [Clinical Data Analysis](#7-clinical-data-analysis)
8. [Equivalence Assessment](#8-equivalence-assessment)
9. [Benefit-Risk Analysis](#9-benefit-risk-analysis)
10. [Conclusions](#10-conclusions)
11. [Appendices](#11-appendices)

---

## 1. Executive Summary

**[Brief summary of clinical evaluation findings, typically 1-2 pages]**

### 1.1 Key Findings

- **Overall Safety**: [Summary statement on device safety]
- **Overall Performance**: [Summary statement on device performance]
- **Benefit-Risk Profile**: [Summary statement on benefit-risk balance]
- **Clinical Data Sources**: [Number of studies, literature sources, etc.]

### 1.2 Clinical Conclusions

[Provide concise conclusion on whether clinical safety and performance are demonstrated]

---

## 2. Scope and Purpose

### 2.1 Scope of Clinical Evaluation

This Clinical Evaluation Report covers:

- Device name and model: [Enter device information]
- Intended purpose: [Enter intended purpose]
- Indications for use: [Enter indications]
- Target population: [Enter target patient population]
- Clinical evaluation period: [Enter period]

### 2.2 Purpose of Document

The purpose of this CER is to:

1. Demonstrate clinical safety and performance of the device
2. Comply with MEDDEV 2.7.1 rev 4 requirements
3. Support EU MDR Article 56 and Annex XIV requirements
4. Provide traceability of clinical data to conclusions

### 2.3 Regulatory Framework

This clinical evaluation is conducted in accordance with:

- **EU MDR 2017/745**: Articles 56, 61, Annex XIV, Annex XV
- **MEDDEV 2.7.1 rev 4**: Clinical Evaluation: A Guide for Manufacturers
- **Relevant Consensus Standards**: ISO 14155, ISO 14971

---

## 3. Device Description

### 3.1 Device Identification

| Attribute | Description |
|-----------|-------------|
| **Device Name** | [Enter device name] |
| **Model Numbers** | [Enter model variants] |
| **Device Classification** | [Enter MDR risk class] |
| **UDI-DI** | [Enter UDI-DI] |
| **Intended Use Environment** | [Professional use, home use, etc.] |

### 3.2 Technology and Principles of Operation

[Describe device technology, mechanism of action, and operational principles]

### 3.3 Device Variants and Accessories

[List all device variants, configurations, and accessories covered by this evaluation]

---

## 4. Intended Purpose and Indications for Use

### 4.1 Intended Purpose

[State the intended purpose of the device as per IFU]

### 4.2 Indications for Use

1. [Indication 1]
2. [Indication 2]
3. [Indication 3]

### 4.3 Contraindications

[List all contraindications for device use]

### 4.4 Warnings and Precautions

[Summarize key warnings and precautions]

### 4.5 Target Population

[Describe intended patient population, including age ranges, conditions, etc.]

---

## 5. Clinical Evaluation Methodology

### 5.1 Evaluation Process

This clinical evaluation follows the MEDDEV 2.7.1 rev 4 four-stage process:

- **Stage 1: Scope Definition** - Completed (see Section 2)
- **Stage 2: Literature Search and Data Collection** - See Section 6
- **Stage 3: Data Appraisal and Analysis** - See Section 7
- **Stage 4: CER Generation** - This document

### 5.2 Data Sources

Clinical data was obtained from:

1. **Clinical Investigation**: [Description of sponsored studies]
2. **Scientific Literature**: [Description of literature sources]
3. **Equivalent Device Data**: [Description of equivalence claims]
4. **Post-Market Surveillance**: [PMS data summary]

### 5.3 Appraisal Criteria

Clinical data was appraised using:

- Study design appropriateness
- Sample size and statistical power
- Endpoint relevance
- Follow-up duration adequacy
- Bias and confounding factor assessment

---

## 6. Literature Search Strategy

### 6.1 Search Protocol

| Parameter | Value |
|-----------|-------|
| **Search Databases** | PubMed, Embase, Cochrane, CINAHL, Web of Science |
| **Search Period** | [Start date] to [End date] |
| **Last Search Date** | [Enter date] |
| **Search Strategy** | [Attach detailed search strategy] |

### 6.2 Search Terms

**Primary Search Concepts**:

1. [Device type/technology] AND [clinical indication]
2. [Alternative term] AND [clinical endpoint]
3. [Comparator device] AND [outcome measure]

### 6.3 Inclusion/Exclusion Criteria

**Inclusion Criteria**:

- Peer-reviewed publications
- Human studies
- Relevant clinical endpoints
- Minimum follow-up: [specify duration]

**Exclusion Criteria**:

- Animal studies (unless relevant for safety)
- Non-clinical research
- Opinion pieces without data
- Studies in unrelated indications

### 6.4 Literature Search Results

| Database | Results Found | Duplicates | After Screening | Included |
|----------|---------------|------------|-----------------|----------|
| PubMed | [Number] | [Number] | [Number] | [Number] |
| Embase | [Number] | [Number] | [Number] | [Number] |
| Cochrane | [Number] | [Number] | [Number] | [Number] |
| **Total** | **[Number]** | **[Number]** | **[Number]** | **[Number]** |

### 6.5 Literature Reference List

[List all included literature with full citations and appraisal]

---

## 7. Clinical Data Analysis

### 7.1 Clinical Investigation Data

#### Study 1: [Study Title]

| Attribute | Description |
|-----------|-------------|
| **Study ID** | [Enter identifier] |
| **Study Design** | [RCT, cohort, case-control, etc.] |
| **Sample Size** | [N=XXX] |
| **Follow-up Duration** | [XXX months] |
| **Primary Endpoint** | [Specify endpoint] |
| **Key Findings** | [Summarize results] |
| **Safety Results** | [Summarize adverse events] |

**Study Appraisal**: [Assess study quality and relevance]

### 7.2 Scientific Literature Analysis

#### Literature Category 1: [Category Name]

- **Number of Studies**: [X]
- **Total Patients**: [N=XXX]
- **Evidence Level**: [I, II, III, IV per Oxford CEBM]
- **Key Findings**: [Synthesize findings]

#### Literature Category 2: [Category Name]

[Repeat above structure]

### 7.3 Post-Market Surveillance Data

| PMS Source | Time Period | Key Findings |
|-------------|-------------|--------------|
| Complaints | [Period] | [Summary] |
| Adverse Events | [Period] | [Summary] |
| Field Safety Corrective Actions | [Period] | [Summary] |
| Post-Market Clinical Follow-up | [Period] | [Summary] |

---

## 8. Equivalence Assessment

### 8.1 Equivalence Claim

**Target Device**: [Enter device name]
**Comparator Device(s)**: [Enter equivalent device(s)]

### 8.2 Equivalence Criteria Assessment

#### 8.2.1 Technical Equivalence

| Criterion | Target Device | Comparator | Assessment |
|-----------|---------------|------------|------------|
| **Same technology** | [Yes/No] | [Description] | [Satisfied/Not satisfied] |
| **Same intended use** | [Yes/No] | [Description] | [Satisfied/Not satisfied] |
| **Similar operating principle** | [Yes/No] | [Description] | [Satisfied/Not satisfied] |

#### 8.2.2 Biological Equivalence

| Criterion | Target Device | Comparator | Assessment |
|-----------|---------------|------------|------------|
| **Same contact tissues** | [Yes/No] | [Description] | [Satisfied/Not satisfied] |
| **Same contact duration** | [Yes/No] | [Description] | [Satisfied/Not satisfied] |
| **Similar materials** | [Yes/No] | [Description] | [Satisfied/Not satisfied] |

#### 8.2.3 Clinical Equivalence

| Criterion | Target Device | Comparator | Assessment |
|-----------|---------------|------------|------------|
| **Same clinical condition** | [Yes/No] | [Description] | [Satisfied/Not satisfied] |
| **Same site of use** | [Yes/No] | [Description] | [Satisfied/Not satisfied] |
| **Same user profile** | [Yes/No] | [Description] | [Satisfied/Not satisfied] |

### 8.3 Equivalence Conclusion

**Equivalence Established**: [Yes/No]

**Justification**: [Provide detailed justification for equivalence conclusion]

---

## 9. Benefit-Risk Analysis

### 9.1 Clinical Benefits

| Benefit | Evidence | Magnitude |
|---------|----------|-----------|
| [Benefit 1] | [Cite studies] | [High/Medium/Low] |
| [Benefit 2] | [Cite studies] | [High/Medium/Low] |
| [Benefit 3] | [Cite studies] | [High/Medium/Low] |

### 9.2 Clinical Risks

| Risk | Likelihood | Severity | Mitigation Measures |
|------|------------|----------|---------------------|
| [Risk 1] | [High/Medium/Low] | [Serious/Moderate/Mild] | [Describe] |
| [Risk 2] | [High/Medium/Low] | [Serious/Moderate/Mild] | [Describe] |
| [Risk 3] | [High/Medium/Low] | [Serious/Moderate/Mild] | [Describe] |

### 9.3 Benefit-Risk Assessment

**Overall Benefit-Risk Profile**: [Favorable/Unfavorable/Equivocal]

**Rationale**:

[Provide detailed analysis of how benefits outweigh risks, including:

- Comparison to alternative treatments
- Residual risks with appropriate mitigations
- Unmet medical needs addressed
- Impact on quality of life
- Clinical significance of benefits]

---

## 10. Conclusions

### 10.1 Clinical Safety Conclusion

[State whether clinical safety is demonstrated based on evaluated data]

**Evidence Summary**:

- Adverse event profile: [Summary]
- Safety signals: [Identified/None identified]
- Risk mitigation effectiveness: [Assessment]

### 10.2 Clinical Performance Conclusion

[State whether clinical performance is demonstrated based on evaluated data]

**Evidence Summary**:

- Primary endpoint achievement: [Summary]
- Performance consistency: [Summary]
- Comparison to alternatives: [Summary]

### 10.3 Overall Clinical Evaluation Conclusion

**The clinical data demonstrates that the [Device Name]:**

1. **Safety**: [Demonstrated/Not demonstrated]
2. **Performance**: [Demonstrated/Not demonstrated]
3. **Benefit-Risk Profile**: [Favorable/Unfavorable]

### 10.4 PMCF Requirements

**Is Post-Market Clinical Follow-up required?**: [Yes/No]

**Justification**:

[If Yes, specify PMCF plan requirements]

---

## 11. Appendices

### Appendix A: Literature Search Strategy

[Full search strategy for each database]

### Appendix B: Study Quality Assessment Tools

[Copies of assessment tools used (e.g., CONSORT, STROBE, QUADAS)]

### Appendix C: Data Extraction Tables

[Detailed data extraction for each included study]

### Appendix D: Post-Market Surveillance Reports

[PMS data summaries and trend analyses]

### Appendix E: Glossary

| Term | Definition |
|------|------------|
| CER | Clinical Evaluation Report |
| PMCF | Post-Market Clinical Follow-up |
| PMS | Post-Market Surveillance |
| MEDDEV | Medical Device Guidance |

---

## Document Control

| Information | Details |
|-------------|---------|
| **Document Owner** | [Name, Title] |
| **Approved By** | [Name, Title, Signature] |
| **Approval Date** | [Date] |
| **Review Date** | [Date - typically annually] |
| **Next Update** | [Date] |

---

**END OF CLINICAL EVALUATION REPORT TEMPLATE**

---

## Template Usage Notes

1. **Customization Instructions**:
   - Replace all bracketed [text] with device-specific information
   - Remove sections not applicable to your device
   - Add additional sections as required by device complexity

2. **Validation Checklist**:
   - All sections completed as applicable
   - Literature search documented per MEDDEV 2.7.1 rev 4
   - Clinical data traceability maintained
   - Benefit-risk analysis completed
   - PMCF requirements addressed

3. **Version Control**:
   - Maintain version history in Section 1.2
   - Archive previous versions with justification for changes
   - Update template when regulatory requirements change
